Cargando…
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
Huntington’s disease is characterized by a complex and heterogeneous pathogenic profile. Studies have shown that disturbance in lipid homeostasis may represent a critical determinant in the progression of several neurodegenerative disorders. The recognition of perturbed lipid metabolism is only rece...
Autores principales: | Di Pardo, Alba, Amico, Enrico, Basit, Abdul, Armirotti, Andrea, Joshi, Piyush, Neely, M. Diana, Vuono, Romina, Castaldo, Salvatore, Digilio, Anna F., Scalabrì, Francesco, Pepe, Giuseppe, Elifani, Francesca, Madonna, Michele, Jeong, Se Kyoo, Park, Bu-Mahn, D’Esposito, Maurizio, Bowman, Aaron B., Barker, Roger A., Maglione, Vittorio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509685/ https://www.ncbi.nlm.nih.gov/pubmed/28706199 http://dx.doi.org/10.1038/s41598-017-05709-y |
Ejemplares similares
-
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
por: Di Pardo, Alba, et al.
Publicado: (2018) -
Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial in a Huntington’s Disease Pre-clinical Model
por: Di Pardo, Alba, et al.
Publicado: (2019) -
De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease
por: Di Pardo, Alba, et al.
Publicado: (2017) -
Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease
por: Di Pardo, Alba, et al.
Publicado: (2017) -
Tractography of the Corpus Callosum in Huntington’s Disease
por: Phillips, Owen, et al.
Publicado: (2013)